Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Stenosis | 17 | 2024 | 857 | 3.250 |
Why?
|
Plaque, Atherosclerotic | 20 | 2024 | 1529 | 2.760 |
Why?
|
Leukemia, Myeloid, Acute | 13 | 2024 | 3637 | 1.940 |
Why?
|
Gene Rearrangement | 8 | 2022 | 1143 | 1.720 |
Why?
|
Gene Fusion | 9 | 2022 | 357 | 1.720 |
Why?
|
Carotid Artery Diseases | 11 | 2024 | 872 | 1.640 |
Why?
|
Oncogene Proteins, Fusion | 12 | 2024 | 1609 | 1.520 |
Why?
|
Carotid Arteries | 15 | 2024 | 932 | 1.400 |
Why?
|
Tandem Repeat Sequences | 2 | 2022 | 184 | 1.390 |
Why?
|
Myelodysplastic Syndromes | 8 | 2024 | 1404 | 1.290 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2022 | 1559 | 1.260 |
Why?
|
Endarterectomy, Carotid | 7 | 2023 | 556 | 1.230 |
Why?
|
Eosinophilia | 4 | 2022 | 553 | 1.190 |
Why?
|
High-Throughput Nucleotide Sequencing | 16 | 2024 | 3665 | 1.170 |
Why?
|
Hematologic Neoplasms | 6 | 2024 | 1926 | 1.160 |
Why?
|
Bone Marrow | 7 | 2023 | 2916 | 0.990 |
Why?
|
RNA-Binding Protein EWS | 3 | 2021 | 211 | 0.890 |
Why?
|
Estrogen Receptor alpha | 2 | 2018 | 580 | 0.860 |
Why?
|
In Situ Hybridization, Fluorescence | 11 | 2023 | 2510 | 0.860 |
Why?
|
Plasmacytoma | 1 | 2023 | 171 | 0.800 |
Why?
|
Pancytopenia | 2 | 2020 | 102 | 0.780 |
Why?
|
Burkitt Lymphoma | 2 | 2022 | 338 | 0.770 |
Why?
|
Mutation | 33 | 2024 | 30209 | 0.750 |
Why?
|
Nanopores | 1 | 2021 | 45 | 0.710 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 230 | 0.710 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2021 | 496 | 0.680 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 | 2020 | 685 | 0.670 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 353 | 0.670 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 24 | 0.670 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 125 | 0.660 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 168 | 0.660 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 119 | 0.650 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 183 | 0.640 |
Why?
|
RNA Helicases | 1 | 2020 | 144 | 0.630 |
Why?
|
Janus Kinase 2 | 2 | 2021 | 562 | 0.620 |
Why?
|
Thrombocytosis | 1 | 2018 | 88 | 0.610 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2024 | 2946 | 0.600 |
Why?
|
Back Pain | 2 | 2019 | 546 | 0.600 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 196 | 0.570 |
Why?
|
Neoplasms | 11 | 2023 | 22344 | 0.560 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2019 | 176 | 0.560 |
Why?
|
Myeloproliferative Disorders | 3 | 2024 | 615 | 0.550 |
Why?
|
Genes, abl | 2 | 2009 | 69 | 0.540 |
Why?
|
Specimen Handling | 1 | 2021 | 704 | 0.520 |
Why?
|
Humans | 155 | 2024 | 766117 | 0.520 |
Why?
|
Lymphoma | 2 | 2022 | 1896 | 0.510 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 273 | 0.510 |
Why?
|
Stroke | 6 | 2023 | 9748 | 0.500 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2019 | 954 | 0.500 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 698 | 0.490 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2018 | 429 | 0.470 |
Why?
|
Hemorrhage | 5 | 2022 | 3466 | 0.470 |
Why?
|
DNA Helicases | 1 | 2020 | 852 | 0.460 |
Why?
|
Carcinoma, Lobular | 1 | 2018 | 471 | 0.460 |
Why?
|
Salivary Gland Neoplasms | 2 | 2022 | 306 | 0.460 |
Why?
|
Calcinosis | 4 | 2024 | 1475 | 0.430 |
Why?
|
Sequence Analysis, DNA | 3 | 2021 | 4780 | 0.420 |
Why?
|
Karyotyping | 1 | 2015 | 1175 | 0.420 |
Why?
|
Skin | 2 | 2019 | 4482 | 0.420 |
Why?
|
Medical Informatics | 1 | 2020 | 743 | 0.420 |
Why?
|
Sezary Syndrome | 1 | 2013 | 70 | 0.410 |
Why?
|
Translocation, Genetic | 6 | 2022 | 1393 | 0.400 |
Why?
|
Precancerous Conditions | 1 | 2019 | 975 | 0.400 |
Why?
|
Carcinoma, Ductal | 1 | 2012 | 97 | 0.400 |
Why?
|
Multiple Myeloma | 4 | 2024 | 5189 | 0.390 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 943 | 0.380 |
Why?
|
Aged | 57 | 2024 | 171219 | 0.370 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2012 | 328 | 0.360 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2024 | 249 | 0.350 |
Why?
|
Piperazines | 6 | 2020 | 2547 | 0.350 |
Why?
|
Trypanocidal Agents | 2 | 2020 | 40 | 0.340 |
Why?
|
Anemia | 1 | 2019 | 1514 | 0.340 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2559 | 0.340 |
Why?
|
Phosphoproteins | 1 | 2018 | 2445 | 0.330 |
Why?
|
Pyrimidines | 7 | 2020 | 3050 | 0.330 |
Why?
|
Male | 71 | 2024 | 363935 | 0.320 |
Why?
|
Laboratories | 2 | 2024 | 463 | 0.320 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2015 | 1374 | 0.320 |
Why?
|
Sarcoma | 4 | 2021 | 1801 | 0.320 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2009 | 121 | 0.320 |
Why?
|
Lymph Nodes | 3 | 2017 | 3456 | 0.310 |
Why?
|
Cytogenetic Analysis | 3 | 2021 | 270 | 0.310 |
Why?
|
Growth Inhibitors | 2 | 2020 | 375 | 0.310 |
Why?
|
Thymus Neoplasms | 2 | 2023 | 271 | 0.310 |
Why?
|
Immunohistochemistry | 9 | 2022 | 11035 | 0.310 |
Why?
|
DNA Mutational Analysis | 4 | 2022 | 4112 | 0.310 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 309 | 0.310 |
Why?
|
Middle Aged | 58 | 2024 | 223083 | 0.300 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 540 | 0.300 |
Why?
|
Immunophenotyping | 4 | 2022 | 1865 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2024 | 5336 | 0.300 |
Why?
|
Neoplasms, Second Primary | 2 | 2014 | 1056 | 0.290 |
Why?
|
Adenocarcinoma | 3 | 2022 | 6363 | 0.290 |
Why?
|
Chemokines, CC | 1 | 2009 | 285 | 0.290 |
Why?
|
Prognosis | 14 | 2024 | 29912 | 0.290 |
Why?
|
Mosaicism | 2 | 2021 | 481 | 0.290 |
Why?
|
Female | 72 | 2024 | 396233 | 0.280 |
Why?
|
Lymphoma, T-Cell | 2 | 2021 | 308 | 0.280 |
Why?
|
Interferon Regulatory Factors | 1 | 2009 | 271 | 0.280 |
Why?
|
Hodgkin Disease | 1 | 2015 | 1383 | 0.280 |
Why?
|
Atherosclerosis | 5 | 2024 | 3418 | 0.280 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2022 | 1621 | 0.280 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2021 | 97 | 0.280 |
Why?
|
Gene Frequency | 3 | 2020 | 3623 | 0.270 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21074 | 0.270 |
Why?
|
World Health Organization | 3 | 2024 | 1326 | 0.270 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2022 | 698 | 0.270 |
Why?
|
Aged, 80 and over | 28 | 2024 | 59515 | 0.270 |
Why?
|
Treponema pallidum | 2 | 2018 | 48 | 0.270 |
Why?
|
Diagnosis, Differential | 8 | 2022 | 12976 | 0.270 |
Why?
|
Laboratory Proficiency Testing | 2 | 2024 | 20 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 9 | 2022 | 5695 | 0.260 |
Why?
|
Genetic Testing | 4 | 2021 | 3594 | 0.250 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2012 | 2877 | 0.250 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 657 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2023 | 2425 | 0.240 |
Why?
|
Neoplasm, Residual | 2 | 2023 | 1009 | 0.240 |
Why?
|
Young Adult | 23 | 2022 | 59868 | 0.240 |
Why?
|
Interferon Type I | 1 | 2009 | 568 | 0.240 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5836 | 0.240 |
Why?
|
Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
Adult | 47 | 2024 | 223139 | 0.230 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13483 | 0.230 |
Why?
|
Uric Acid | 2 | 2022 | 809 | 0.220 |
Why?
|
Gastrointestinal Tract | 2 | 2022 | 834 | 0.220 |
Why?
|
Purpura Fulminans | 1 | 2024 | 21 | 0.220 |
Why?
|
Syphilis | 2 | 2018 | 243 | 0.220 |
Why?
|
Oncogene Fusion | 2 | 2021 | 84 | 0.220 |
Why?
|
Retrospective Studies | 21 | 2024 | 81565 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1163 | 0.210 |
Why?
|
Hyperemia | 2 | 2021 | 223 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2024 | 2054 | 0.210 |
Why?
|
Bone Marrow Cells | 4 | 2023 | 2411 | 0.210 |
Why?
|
K562 Cells | 2 | 2018 | 644 | 0.210 |
Why?
|
Methenamine | 1 | 2022 | 4 | 0.210 |
Why?
|
Algorithms | 2 | 2020 | 14066 | 0.200 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6544 | 0.200 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1504 | 0.200 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5791 | 0.200 |
Why?
|
Fatal Outcome | 2 | 2019 | 1836 | 0.200 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13635 | 0.190 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2021 | 15 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 91 | 0.190 |
Why?
|
Xanthine Oxidase | 1 | 2021 | 69 | 0.180 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.180 |
Why?
|
Bone Cysts | 1 | 2021 | 48 | 0.180 |
Why?
|
Receptor, trkA | 1 | 2022 | 159 | 0.180 |
Why?
|
STAT Transcription Factors | 1 | 2021 | 189 | 0.180 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.180 |
Why?
|
Oncogenes | 2 | 2017 | 1232 | 0.180 |
Why?
|
Endometrial Stromal Tumors | 1 | 2021 | 46 | 0.180 |
Why?
|
Adipose Tissue | 2 | 2024 | 3315 | 0.180 |
Why?
|
Janus Kinases | 1 | 2021 | 253 | 0.180 |
Why?
|
Cholangiocarcinoma | 2 | 2017 | 577 | 0.170 |
Why?
|
Leukoaraiosis | 1 | 2021 | 114 | 0.170 |
Why?
|
Bile Duct Neoplasms | 2 | 2017 | 624 | 0.170 |
Why?
|
Trypanosomiasis, African | 1 | 2020 | 30 | 0.170 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2021 | 92 | 0.170 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2021 | 1433 | 0.170 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2017 | 615 | 0.170 |
Why?
|
Carcinoma, Small Cell | 1 | 2022 | 420 | 0.170 |
Why?
|
Ehrlichiosis | 1 | 2020 | 28 | 0.170 |
Why?
|
Uterine Neoplasms | 2 | 2020 | 1425 | 0.170 |
Why?
|
Trypanosoma brucei brucei | 1 | 2020 | 43 | 0.170 |
Why?
|
Blast Crisis | 1 | 2020 | 102 | 0.170 |
Why?
|
Anaplasma phagocytophilum | 1 | 2020 | 37 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2023 | 329 | 0.170 |
Why?
|
Pyridines | 5 | 2020 | 2889 | 0.170 |
Why?
|
Chromosomes, Human, Y | 1 | 2021 | 163 | 0.170 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 125 | 0.170 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5388 | 0.160 |
Why?
|
Trace Elements | 1 | 2021 | 193 | 0.160 |
Why?
|
Endometrial Neoplasms | 2 | 2021 | 1379 | 0.160 |
Why?
|
Signal Transduction | 5 | 2021 | 23605 | 0.160 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.160 |
Why?
|
Alleles | 3 | 2022 | 6892 | 0.160 |
Why?
|
Biological Assay | 1 | 2022 | 626 | 0.160 |
Why?
|
Humerus | 1 | 2021 | 272 | 0.160 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1765 | 0.160 |
Why?
|
Adipocytes | 2 | 2020 | 1196 | 0.160 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 391 | 0.160 |
Why?
|
Prenatal Injuries | 1 | 2018 | 13 | 0.160 |
Why?
|
Myofibroblasts | 1 | 2020 | 230 | 0.150 |
Why?
|
Fibula | 1 | 2021 | 270 | 0.150 |
Why?
|
Coronary Vessels | 3 | 2024 | 3094 | 0.150 |
Why?
|
Bone Marrow Diseases | 1 | 2020 | 234 | 0.150 |
Why?
|
Point Mutation | 1 | 2004 | 1591 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2022 | 343 | 0.150 |
Why?
|
Genotype | 5 | 2021 | 13028 | 0.150 |
Why?
|
Codon, Nonsense | 1 | 2019 | 288 | 0.150 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2020 | 258 | 0.150 |
Why?
|
Peptidomimetics | 1 | 2018 | 31 | 0.150 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 237 | 0.150 |
Why?
|
Incubators, Infant | 1 | 2017 | 6 | 0.150 |
Why?
|
Receptors, Steroid | 1 | 2018 | 156 | 0.150 |
Why?
|
Germ Cells | 1 | 2022 | 646 | 0.150 |
Why?
|
Thymoma | 1 | 2019 | 186 | 0.150 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6059 | 0.150 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 25 | 0.150 |
Why?
|
Trypanosoma cruzi | 1 | 2020 | 203 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 52 | 0.150 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2012 | 904 | 0.150 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2018 | 185 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 11 | 2024 | 20700 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2040 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9378 | 0.140 |
Why?
|
Chordoma | 1 | 2020 | 343 | 0.140 |
Why?
|
Adolescent | 16 | 2022 | 88819 | 0.140 |
Why?
|
Exanthema | 2 | 2019 | 503 | 0.140 |
Why?
|
Antigens, CD19 | 1 | 2020 | 442 | 0.140 |
Why?
|
Myofibroma | 1 | 2017 | 45 | 0.140 |
Why?
|
Chromosome Aberrations | 3 | 2021 | 1775 | 0.140 |
Why?
|
Cathepsins | 1 | 2018 | 242 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2018 | 562 | 0.140 |
Why?
|
Cardiomegaly | 1 | 2019 | 590 | 0.140 |
Why?
|
Trans-Activators | 3 | 2023 | 2849 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8612 | 0.140 |
Why?
|
Child | 11 | 2022 | 80573 | 0.140 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2020 | 361 | 0.130 |
Why?
|
Chromogranins | 1 | 2017 | 159 | 0.130 |
Why?
|
Leukemia | 2 | 2019 | 1522 | 0.130 |
Why?
|
Classification | 1 | 2017 | 128 | 0.130 |
Why?
|
Methamphetamine | 1 | 2018 | 166 | 0.130 |
Why?
|
Cytogenetics | 1 | 2017 | 197 | 0.130 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.130 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 175 | 0.130 |
Why?
|
Liver Failure | 1 | 2018 | 252 | 0.130 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 454 | 0.130 |
Why?
|
Transcription Factors | 5 | 2023 | 12130 | 0.130 |
Why?
|
Pelvic Pain | 1 | 2018 | 300 | 0.130 |
Why?
|
Femur | 2 | 2021 | 1309 | 0.130 |
Why?
|
Carcinoma, Endometrioid | 1 | 2019 | 275 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 506 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2022 | 657 | 0.130 |
Why?
|
Neoplasm Staging | 5 | 2015 | 11200 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 361 | 0.130 |
Why?
|
Electromagnetic Fields | 1 | 2017 | 290 | 0.130 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2017 | 234 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2017 | 312 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 432 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.120 |
Why?
|
Hematuria | 1 | 2017 | 232 | 0.120 |
Why?
|
Benzamides | 5 | 2012 | 1376 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5752 | 0.120 |
Why?
|
Mouth | 1 | 2018 | 383 | 0.120 |
Why?
|
Cysteine Endopeptidases | 1 | 2018 | 542 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 754 | 0.120 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2019 | 488 | 0.120 |
Why?
|
Microcirculation | 1 | 2020 | 1282 | 0.120 |
Why?
|
Lymphatic Diseases | 2 | 2014 | 317 | 0.120 |
Why?
|
Streptococcus bovis | 1 | 2014 | 4 | 0.120 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 181 | 0.120 |
Why?
|
Strongyloides stercoralis | 1 | 2014 | 23 | 0.120 |
Why?
|
Strongyloidiasis | 1 | 2014 | 27 | 0.120 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3238 | 0.120 |
Why?
|
Superinfection | 1 | 2014 | 61 | 0.110 |
Why?
|
Exons | 1 | 2020 | 2393 | 0.110 |
Why?
|
Fibrin | 1 | 2017 | 514 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 614 | 0.110 |
Why?
|
Genomics | 4 | 2023 | 5926 | 0.110 |
Why?
|
Transients and Migrants | 1 | 2016 | 170 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 9 | 2024 | 36548 | 0.110 |
Why?
|
Helminthiasis, Animal | 1 | 2013 | 4 | 0.110 |
Why?
|
Lymphadenitis | 1 | 2014 | 98 | 0.110 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9601 | 0.110 |
Why?
|
Anilides | 1 | 2017 | 413 | 0.110 |
Why?
|
Dermatitis, Exfoliative | 1 | 2013 | 28 | 0.110 |
Why?
|
Peptides | 2 | 2018 | 4338 | 0.110 |
Why?
|
Fish Diseases | 1 | 2013 | 36 | 0.110 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2017 | 858 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 18076 | 0.110 |
Why?
|
Bone Marrow Transplantation | 2 | 2019 | 2729 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 521 | 0.110 |
Why?
|
Molecular Biology | 1 | 2017 | 573 | 0.110 |
Why?
|
Recurrence | 2 | 2024 | 8494 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1319 | 0.100 |
Why?
|
Workflow | 3 | 2023 | 859 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2898 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2017 | 751 | 0.100 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 746 | 0.100 |
Why?
|
Nitriles | 1 | 2018 | 981 | 0.100 |
Why?
|
Pyrazoles | 2 | 2020 | 2031 | 0.100 |
Why?
|
Gene Amplification | 2 | 2018 | 1088 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1068 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1027 | 0.100 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 518 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2023 | 5881 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1762 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 2 | 2017 | 1363 | 0.100 |
Why?
|
Meningitis, Bacterial | 1 | 2014 | 222 | 0.100 |
Why?
|
Machado-Joseph Disease | 1 | 2012 | 26 | 0.100 |
Why?
|
Child, Preschool | 7 | 2021 | 42511 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2662 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1607 | 0.100 |
Why?
|
Immunotherapy | 2 | 2022 | 4746 | 0.100 |
Why?
|
Drug Discovery | 1 | 2020 | 1065 | 0.100 |
Why?
|
Hospitals, General | 1 | 2016 | 803 | 0.100 |
Why?
|
Mesothelioma | 1 | 2018 | 774 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1321 | 0.100 |
Why?
|
Medical Oncology | 2 | 2022 | 2339 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2023 | 2649 | 0.090 |
Why?
|
Endothelium, Vascular | 2 | 2022 | 4423 | 0.090 |
Why?
|
Vincristine | 2 | 2012 | 1037 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2018 | 706 | 0.090 |
Why?
|
Bone Marrow Examination | 2 | 2023 | 155 | 0.090 |
Why?
|
Antimalarials | 1 | 2018 | 909 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1726 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 663 | 0.090 |
Why?
|
Sirolimus | 2 | 2018 | 1541 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2019 | 2974 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2354 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1643 | 0.090 |
Why?
|
Anticonvulsants | 1 | 2020 | 1920 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6768 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1637 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 228 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4521 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3733 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 678 | 0.090 |
Why?
|
Bone and Bones | 1 | 2020 | 2555 | 0.080 |
Why?
|
Streptococcal Infections | 1 | 2014 | 616 | 0.080 |
Why?
|
Pruritus | 1 | 2013 | 376 | 0.080 |
Why?
|
Sepsis | 1 | 2024 | 2603 | 0.080 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3051 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 949 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2018 | 3436 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2105 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 21513 | 0.080 |
Why?
|
Risk Assessment | 4 | 2024 | 24276 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1552 | 0.080 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 17071 | 0.080 |
Why?
|
Stem Cell Transplantation | 2 | 2018 | 1600 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4887 | 0.080 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2039 | 0.080 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 182 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16716 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1306 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2795 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14645 | 0.070 |
Why?
|
Gene Duplication | 2 | 2022 | 316 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 615 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2021 | 190 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2021 | 3002 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 2997 | 0.070 |
Why?
|
Farnesyltranstransferase | 1 | 2007 | 70 | 0.070 |
Why?
|
Molecular Structure | 3 | 2020 | 1881 | 0.070 |
Why?
|
Echocardiography | 1 | 2019 | 5041 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11859 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6409 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2024 | 15403 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3594 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3458 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2012 | 3584 | 0.060 |
Why?
|
Dermatitis, Atopic | 1 | 2013 | 724 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5454 | 0.060 |
Why?
|
Disease Progression | 2 | 2022 | 13616 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2006 | 145 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41684 | 0.060 |
Why?
|
Infant | 4 | 2020 | 36427 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15647 | 0.060 |
Why?
|
Antigens, CD7 | 1 | 2024 | 29 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 40108 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7426 | 0.060 |
Why?
|
Pilot Projects | 4 | 2024 | 8724 | 0.060 |
Why?
|
Risk Factors | 8 | 2024 | 74857 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2018 | 3307 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4782 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3604 | 0.060 |
Why?
|
Glioma | 1 | 2019 | 3491 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2020 | 1331 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6840 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 193 | 0.050 |
Why?
|
Melanoma | 1 | 2022 | 5695 | 0.050 |
Why?
|
src-Family Kinases | 1 | 2006 | 539 | 0.050 |
Why?
|
Receptors, Complement | 1 | 2024 | 240 | 0.050 |
Why?
|
Boston | 3 | 2021 | 9335 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 259 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 220 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4049 | 0.050 |
Why?
|
Thorax | 2 | 2020 | 554 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2593 | 0.050 |
Why?
|
Human papillomavirus 18 | 1 | 2022 | 125 | 0.050 |
Why?
|
Antigens, Neoplasm | 2 | 2024 | 1996 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4425 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8723 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2020 | 26381 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10063 | 0.050 |
Why?
|
Mass Screening | 1 | 2016 | 5450 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4282 | 0.040 |
Why?
|
Base Sequence | 1 | 2012 | 12405 | 0.040 |
Why?
|
Ceramides | 1 | 2022 | 202 | 0.040 |
Why?
|
Co-Repressor Proteins | 1 | 2021 | 190 | 0.040 |
Why?
|
Lipids | 2 | 2022 | 3316 | 0.040 |
Why?
|
Human papillomavirus 16 | 1 | 2022 | 268 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 524 | 0.040 |
Why?
|
Isomerism | 1 | 2020 | 197 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1592 | 0.040 |
Why?
|
Mice | 8 | 2020 | 81839 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 61 | 0.040 |
Why?
|
Animals | 11 | 2024 | 168800 | 0.040 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2020 | 90 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15882 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6215 | 0.040 |
Why?
|
Phosphorus | 1 | 2021 | 336 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2009 | 2060 | 0.040 |
Why?
|
Italy | 2 | 2016 | 851 | 0.040 |
Why?
|
Minnesota | 1 | 2020 | 339 | 0.040 |
Why?
|
Hong Kong | 1 | 2019 | 169 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2024 | 4498 | 0.040 |
Why?
|
Cell Survival | 2 | 2020 | 5747 | 0.040 |
Why?
|
Organizations, Nonprofit | 1 | 2020 | 105 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2824 | 0.040 |
Why?
|
Calcium | 2 | 2023 | 5770 | 0.040 |
Why?
|
Florida | 1 | 2020 | 416 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 411 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2024 | 3360 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Metaplasia | 1 | 2019 | 325 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2021 | 392 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2022 | 575 | 0.040 |
Why?
|
Copper | 1 | 2021 | 365 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1716 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 200 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12827 | 0.040 |
Why?
|
Selenium | 1 | 2021 | 418 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54812 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 427 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1102 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2024 | 1478 | 0.040 |
Why?
|
Magnesium | 1 | 2021 | 815 | 0.040 |
Why?
|
Tretinoin | 1 | 2020 | 524 | 0.030 |
Why?
|
Zinc | 1 | 2021 | 675 | 0.030 |
Why?
|
Morpholines | 1 | 2020 | 584 | 0.030 |
Why?
|
Hyperbilirubinemia | 1 | 2017 | 74 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10737 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 276 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 230 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 147 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9527 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2017 | 313 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3722 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2022 | 1322 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2022 | 1137 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1072 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1589 | 0.030 |
Why?
|
Epistaxis | 1 | 2017 | 119 | 0.030 |
Why?
|
Tyrosine | 1 | 2020 | 1427 | 0.030 |
Why?
|
Intestinal Fistula | 1 | 2017 | 146 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2022 | 1601 | 0.030 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 186 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15808 | 0.030 |
Why?
|
Pain Perception | 1 | 2017 | 197 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
Prednisone | 2 | 2014 | 1566 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1719 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39243 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 864 | 0.030 |
Why?
|
Bartonella Infections | 1 | 2014 | 21 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 16040 | 0.030 |
Why?
|
Chest Pain | 1 | 2022 | 1102 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2017 | 254 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 455 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 65219 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9301 | 0.030 |
Why?
|
Quinolines | 1 | 2020 | 769 | 0.030 |
Why?
|
Plasma Cells | 1 | 2018 | 597 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2015 | 147 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1443 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1889 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1407 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2015 | 322 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 391 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 548 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10260 | 0.030 |
Why?
|
Photophobia | 1 | 2014 | 77 | 0.030 |
Why?
|
Abdomen | 1 | 2020 | 1135 | 0.030 |
Why?
|
Antarctic Regions | 1 | 2013 | 13 | 0.030 |
Why?
|
Antigens, CD | 1 | 2024 | 4025 | 0.030 |
Why?
|
Life Cycle Stages | 1 | 2014 | 161 | 0.030 |
Why?
|
Vaginal Smears | 1 | 2016 | 506 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 647 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2015 | 451 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1790 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14456 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2868 | 0.030 |
Why?
|
Helminths | 1 | 2013 | 39 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20137 | 0.030 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 238 | 0.030 |
Why?
|
Analgesia | 1 | 2017 | 461 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 856 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1054 | 0.030 |
Why?
|
Iron | 1 | 2021 | 1811 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2716 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2902 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 8062 | 0.020 |
Why?
|
Neutropenia | 1 | 2017 | 894 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2430 | 0.020 |
Why?
|
Nausea | 1 | 2014 | 679 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4860 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9354 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3715 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1525 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2019 | 11642 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10087 | 0.020 |
Why?
|
Fishes | 1 | 2013 | 607 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1520 | 0.020 |
Why?
|
Malaria, Falciparum | 1 | 2018 | 1073 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2864 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4399 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2531 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3489 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18321 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1468 | 0.020 |
Why?
|
Tail | 1 | 2009 | 91 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2014 | 865 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9599 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3214 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2009 | 137 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1227 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2012 | 827 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2009 | 268 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2012 | 733 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17535 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2121 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3073 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 858 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3690 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1107 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1943 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3610 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 30233 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5300 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22341 | 0.020 |
Why?
|
Protein Prenylation | 1 | 2007 | 69 | 0.020 |
Why?
|
Software | 1 | 2021 | 4463 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3887 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1338 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1490 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7850 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2235 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3227 | 0.020 |
Why?
|
Adipogenesis | 1 | 2009 | 371 | 0.020 |
Why?
|
Headache | 1 | 2014 | 1259 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5776 | 0.020 |
Why?
|
Carcinoma | 1 | 2017 | 2313 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2016 | 1172 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6612 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4556 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3501 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26290 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10579 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4213 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2014 | 2156 | 0.010 |
Why?
|
Electroencephalography | 1 | 2020 | 6279 | 0.010 |
Why?
|
Histones | 1 | 2015 | 2591 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4249 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2890 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2014 | 4263 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3942 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1677 | 0.010 |
Why?
|
Body Composition | 1 | 2013 | 2441 | 0.010 |
Why?
|
Stromal Cells | 1 | 2009 | 1332 | 0.010 |
Why?
|
Tibia | 1 | 2009 | 1064 | 0.010 |
Why?
|
Mutagenesis | 1 | 2007 | 1227 | 0.010 |
Why?
|
Bleomycin | 1 | 2004 | 491 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18386 | 0.010 |
Why?
|
Etoposide | 1 | 2004 | 636 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4544 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2009 | 10433 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2009 | 943 | 0.010 |
Why?
|
Osteogenesis | 1 | 2009 | 1281 | 0.010 |
Why?
|
Spine | 1 | 2009 | 1132 | 0.010 |
Why?
|
Apoptosis | 2 | 2009 | 9508 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4904 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14747 | 0.010 |
Why?
|
United States | 2 | 2020 | 72920 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8525 | 0.010 |
Why?
|
RNA Interference | 1 | 2009 | 2828 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 2003 | 0.010 |
Why?
|
Pain | 1 | 2014 | 5090 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2007 | 6102 | 0.010 |
Why?
|
Protein Conformation | 1 | 2007 | 3946 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3751 | 0.010 |
Why?
|
Adiposity | 1 | 2009 | 1892 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22228 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1777 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4649 | 0.010 |
Why?
|
Piperidines | 1 | 2007 | 1664 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2232 | 0.010 |
Why?
|
Homeostasis | 1 | 2009 | 3338 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8292 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9065 | 0.010 |
Why?
|
Doxorubicin | 1 | 2004 | 2226 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10860 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8616 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2009 | 3405 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5382 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12803 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6545 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15546 | 0.010 |
Why?
|
Brain | 1 | 2018 | 27177 | 0.010 |
Why?
|